COVID-19 SAFE Enrollment

Completed · Not applicable

Conditions studied: Covid19

In brief

In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. The investigators will evaluate the implementation of a COVID-19 screening program that coordinates several existing systems at the University of Pennsylvania including saliva-based viral testing and test different outreach strategies (opt-in vs opt-out) to improve program enrollment.

Key facts

Study ID

NCT04506268

Run by

University of Pennsylvania

People needed

412

Starts

2020-09-09

Expected to finish

2020-10-30

Last updated by the study team

2021-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• University of Pennsylvania staff, faculty, and trainees that have returned to work on campus who have been identified by leadership at the University of Pennsylvania Perelman School of Medicine.

You may not qualify if…

• Participants will not be eligible for the study if they identify any reason they are unable to participate in the study.

Where it is running

• Penn Medicine — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.